Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 2Phase NA 1Phase 1 1

Status

Completed 17Unknown 8Recruiting 8Active not recruiting 8Terminated 6Withdrawn 2

Sponsor Class

OTHER 5NIH 2INDUSTRY 1

Study Type

Interventional 6Observational 2

Sponsor

Cancer Type

Dermatologic 8Thoracic 1

Conditions

Melanoma 8Carcinoma, Non-Small-Cell Lung 6Breast Neoplasms 5Pancreatic Neoplasms 4Neoplasms 4Colorectal Neoplasms 4Stomach Neoplasms 3Prostatic Neoplasms 3Head and Neck Neoplasms 3Esophageal Neoplasms 3Carcinoma, Basal Cell 3Barrett Esophagus 3Squamous Cell Carcinoma of Head and Neck 2Rectal Neoplasms 2Ovarian Neoplasms 2Neuroendocrine Tumors 2Lung Neoplasms 2Liver Neoplasms 2Inflammatory Bowel Diseases 2Colonic Neoplasms 2Breast Neoplasms, Male 2Uveal Melanoma 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Tuberculosis 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Thyroid Diseases 1Squamous Intraepithelial Lesions 1Small Cell Lung Carcinoma 1

Interventions

Nivolumab 23pembrolizumab 19Ipilimumab 13toripalimab 12Temozolomide 11Biopsy 8Dacarbazine 7Blood Specimen Collection 6trametinib 5dabrafenib 5camrelizumab 5atezolizumab 5Gene Expression Profiling 5Cyclophosphamide 5Chemotherapy, Adjuvant 5fludarabine 4durvalumab 4binimetinib 4aldesleukin 4Injections 4tislelizumab 3palbociclib 3encorafenib 3apatinib 3Sorafenib 3Introns 3Interleukin-2 3Drug Therapy 3Cisplatin 3Carboplatin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
Unknown × Melanoma × Biopsy × Clear all
NCT02977052 2023-11-15

OpACIN-neo

The Netherlands Cancer Institute

Phase 2 Unknown
186 enrolled
Dermatologic

Melanoma

NCT05906277 2023-06-15

Melamoma4p

Regina Elena Cancer Institute

Phase NA Unknown
300 enrolled
Dermatologic

Melanoma

NCT04136470 2020-08-10

BioForte Technology for in Silico Identification of Candidates for a New Microbiome-based Therapeutics and Diagnostics

Ardigen

Unknown
130 enrolled
DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma, Neoplasms

NCT02654821 2018-11-02

TCR

The Netherlands Cancer Institute

Phase 1/2 Unknown
12 enrolled
Dermatologic

Uveal Melanoma, Melanoma

NCT02625337 2017-09-15

IMPemBra

The Netherlands Cancer Institute

Phase 2 Unknown
32 enrolled
Dermatologic

Melanoma

NCT02938728 2016-10-25

PREDIMEL

Assistance Publique - Hôpitaux de Paris

Unknown
120 enrolled
Dermatologic

Melanoma

NCT00391300 2013-12-18

Bioelectric Field Imaging in Diagnosing Melanoma and Other Skin Cancers in Patients With Skin Lesions

National Cancer Institute (NCI)

Phase 1 Unknown
100 enrolled
Dermatologic

Carcinoma, Basal Cell, Melanoma

NCT00811759 2010-10-07

Sorafenib and Temozolomide in Treating Patients With Stage III or Stage IV Melanoma

National Cancer Institute (NCI)

Phase 1/2 Unknown
58 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡